Diagnostic value of history in patients with syncope with or without heart disease  by Alboni, Paolo et al.
Diagnostic Value of History in Patients
With Syncope With or Without Heart Disease
Paolo Alboni, MD, FACC,* Michele Brignole, MD,† Carlo Menozzi, MD,‡ Antonio Raviele, MD,§
Attilio Del Rosso, MD,\ Maurizio Dinelli, MD,* Alberto Solano, MD,† Nicola Bottoni, MD‡
Cento, Lavagna, Reggio Emilia, Mestre and Fucecchio, Italy
OBJECTIVES We sought to establish what historical findings are predictive of the cause of syncope.
BACKGROUND The clinical features of the various types of syncope have not been systematically investigated.
METHODS Three hundred forty-one patients with syncope were prospectively evaluated. Each patient
was interviewed using a standard questionnaire. A cause of syncope was assigned using
standardized diagnostic criteria.
RESULTS A cardiac cause of syncope was established in 23% of the patients, a neurally mediated cause
in 58% and a neurologic or psychiatric cause in 1%, and in the remaining 18%, the cause of
syncope remained unexplained. In a preliminary analysis including age, gender and the
presence of suspected or certain heart disease after the initial evaluation, only heart disease
was an independent predictor of a cardiac cause of syncope (odds ratio 16, p 5 0.00001), with
a sensitivity of 95% and a specificity of 45%. In contrast, the absence of heart disease allowed
us to exclude a cardiac cause of syncope in 97% of the patients. In patients with certain or
suspected heart disease, the most specific predictors of a cardiac cause were syncope in the
supine position or during effort, blurred vision and convulsive syncope. Significant and
specific predictors of a neurally mediated cause were time between the first and last syncopal
episode .4 years, abdominal discomfort before the loss of consciousness and nausea and
diaphoresis during the recovery phase. In the patients without heart disease, palpitation was
the only significant predictor of a cardiac cause.
CONCLUSIONS The presence of suspected or certain heart disease after the initial evaluation is a strong
predictor of a cardiac cause of syncope. A few historical findings are useful to predict cardiac
and neurally mediated syncope in patients with and without heart disease. (J Am Coll
Cardiol 2001;37:1921–8) © 2001 by the American College of Cardiology
It is commonly accepted that history is an essential part of
the work-up of patients with syncope. The historical find-
ings, per se, may be diagnostic of the cause of syncope or
may suggest a strategy of evaluation. Several clinical features
regarding the modalities of presentation, the factors that
might predispose to the syncopal attack and the sequelae of
syncope have been utilized. However, their diagnostic value
is generally accepted on the basis of common sense, personal
experience, pathophysiologic knowledge and anecdotal re-
ports. This is the case of symptoms such as nausea,
diaphoresis, pallor, abdominal discomfort and yawning,
which are commonly considered characteristic of neurally
mediated syncope.
The aim of the present study was to establish what
historical findings are predictive of the cause of syncope.
METHODS
Patients were recruited if they had a syncopal episode in the
previous two months (defined as a brief, self-limited loss of
consciousness with the inability to maintain postural tone)
and were $18 years. Three hundred fifty-six consecutive
patients with the aforementioned characteristics were re-
ferred to the “Syncope Unit” of the Cardiology Division of
three hospitals (Cento, Lavagna and Reggio Emilia, Italy)
from the emergency room, in-patient service and out-
patient clinic between January and July 1999. All patients
underwent a standardized initial evaluation consisting of a
history, physical and neurologic examinations performed by
one of the investigators, evaluation of blood pressure in the
supine and standing positions and standard electrocardio-
gram (ECG). Conventional laboratory tests were performed
when a hemorrhagic or metabolic cause was suspected.
When the results of the initial evaluation allowed us to
define the cause of syncope (i.e., diagnostic [see subsequent
text]), the procedures were interrupted. When the results of
the initial evaluation were inconclusive, further investiga-
tions were performed according to the guidelines of the
Italian “Associazione Nazionale Medici Cardiologi Osped-
alieri” (1,2) (Fig. 1), with the addition of the adenosine
triphosphate (ATP) test when the cause of syncope re-
mained unexplained at the end of the diagnostic work-up.
For example, patients with certain or suspected heart disease
first underwent noninvasive cardiac examinations, as appro-
priate, and, in the event of negative results, an electrophysi-
ologic study. Patients without signs of heart disease first
underwent carotid sinus massage and the tilt test. In the
event of focal neurologic symptoms before or after the loss
of consciousness, witnessed prolonged loss of consciousness
with tonic-clonic movements or a post-ictal state, migraine
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or signs of psychiatric disorders, a consultant neurologist or
psychiatrist was called in. At his or her discretion, neuro-
logic examinations were performed.
We classified the causes of syncopes, as reported in Table
1. Diagnostic criteria for the causes of syncope were devel-
oped before enrollment, on the basis of an extensive review
of the pertinent published data, and assignment of a cause
was based on strict adherence to these criteria. The diag-
nosis was assigned by one of the investigators at the end of
the diagnostic procedures. Presumed diagnoses made by the
house staff or attending physician were not accepted. Syn-
cope was defined as orthostatic in the presence of a decrease
in systolic blood pressure $20 mm Hg during 5 min after
the patient assumed the upright position, associated with
dizziness or syncope (3,4); typical vasovagal if a precipitating
event, such as fear, severe pain, strong emotion or instru-
mentation, could be identified in the absence of another
competing diagnosis for the cause of syncope (3); situational
syncope when the loss of consciousness occurred during or
immediately after urination, defecation, coughing or swal-
lowing (3); tilt-induced syncope when the loss of conscious-
ness was induced during the tilt test, as previously described
Abbreviations and Acronyms
ATP 5 adenosine triphosphate
AV 5 atrioventricular
ECG 5 electrocardiogram or electrocardiographic
Figure 1. Algorithm for diagnostic approach to syncope proposed by the Italian “Associazione Nazionale Medici Cardiologi Ospedalieri” (1,2), modified
with the introduction of the adenosine triphosphate (ATP) test. Circled minus sign 5 not a diagnostic examination; ? 5 indication to be evaluated case
by case; CAT 5 computed axial tomography; CSM 5 carotid sinus massage; ECHO 5 echocardiogram; EEG 5 electroencephalogram; ES 5
electrophysiologic study; ET 5 exercise test.
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(5); carotid sinus syncope when carotid sinus massage, per-
formed both in the supine and upright positions, induced
syncope in the presence of bradycardia or hypotension, or
both (6); drug-induced syncope when a clear temporal rela-
tionship between drug assumption and syncope could be
proven; adenosine-sensitive syncope if a bolus of 20 mg of
ATP induced a cardiac pause $6 s (7); and mechanical
cardiac syncope in the presence of severe valvular stenosis or
other flow obstruction. Arrhythmic syncope was diagnosed on
the basis of standard ECG or 24-h Holter recordings or
during the electrophysiologic study. The following findings
of standard ECG were considered diagnostic: sinus brady-
cardia ,40 beats/min or repetitive sinoatrial blocks or sinus
pauses .3 s; Mobitz II or advanced (2:1, 3:1, etc.) second-
degree atrioventricular (AV) block or third-degree AV
block; atrial fibrillation with a slow ventricular response
(mean heart rate ,50 beats/min); and sustained supraven-
tricular or ventricular tachyarrhythmias. The following find-
ings of 24-h Holter recording were considered diagnostic:
any arrhythmia associated with syncope or presyncope, or,
in the absence of neurologic symptoms, Mobitz II or
advanced degree or third-degree AV block; and sustained
ventricular tachyarrhythmias. The following electrophysi-
ologic findings were considered diagnostic: sinus node
recovery time .3 s; baseline HV interval $100 ms or
appearance of infra-hisian second- or third-degree AV
block during atrial pacing or after ajmaline administration;
and induction of syncopal or hypotensive supraventricular or
ventricular tachyarrhythmias. Metabolic syncope due to hypo-
glycemia was diagnosed when the loss of consciousness was
preceded by tremors, confusion, salivation, hunger and a
hyperadrenergic state, and glycemia was ,40 mg/dl.
Syncope questionnaire. The clinical findings of syncope
were investigated, taking into account the last syncopal
episode, by one of the authors, who used a standard
questionnaire. The questionnaire was designed to identify
46 findings of the index syncopal episode. Data were
collected on precipitating and predisposing factors; prodro-
mal and recovery symptoms; the duration of the prodromal
symptoms, loss of consciousness and recovery phase; and
physical signs. The duration of the loss of consciousness and
physical signs was investigated only if they were observed by
witnesses, who were interviewed. The variables investigated
are reported in Table 2.
Definitions. After the initial evaluation, the presence of
heart disease was suspected or diagnosed on the basis of
history, physical examination or ECG abnormalities, or a
combination of these. Supraventricular or ventricular tachy-
cardia was defined as sustained (lasting .30 s) if present on
the standard ECG recorded in the emergency room or 24-h
Holter recording. The ECG was considered abnormal,
besides the alterations reported earlier (see Methods), in the
presence of signs of atrial or ventricular enlargement,
intraventricular conduction disturbances, ventricular pre-
excitation, old myocardial infarction, isolated sinoatrial
block and in the presence of first- or second-degree Wencke-
bach AV block, ST segment and T-waves abnormalities and
rhythm abnormalities, such as atrial fibrillation or flutter,
atrial tachycardia, junctional or paced rhythm, and frequent
or repetitive premature ventricular beats.
Statistical analysis. Comparisons between groups were
performed by means of the Fisher exact test, t test or
rank-sum test, as appropriate. The logistic regression test
was used to find those variables that were independent
predictors of the cause of syncope. The data were analyzed
with the StatSoft software (Version 5.1, 1997, Tulsa,
Oklahoma).
RESULTS
During the recruitment period, 356 patients were enrolled
(Fig. 2). Of these, 15 (4%) were excluded due to an
incomplete evaluation or protocol violation. Therefore, 341
patients were analyzed. The mean age of the patients was
61 6 20 years; 184 were men.
A cardiac cause of syncope was established in 78 patients
(23%), a neurally mediated cause in 199 (58%) and a
neurologic or psychiatric cause in 4 (1%), and in the
remaining 60 (18%) the cause of syncope remained unex-
plained (Table 1). The diagnostic tests that established the
cause of syncope are reported in Table 3. Because only four
patients had a neurologic or psychiatric cause, this group
was not included in the statistical analysis. Therefore, 337
patients were evaluated.
Of 51 patients with bradyarrhythmia, AV block was
present in 40, sinus node dysfunction in 6 and atrial
fibrillation with a slow ventricular response in 5. Of 17
patients with tachyarrhythmia, supraventricular tachycardia
was present in 4 and ventricular tachycardia in 13. Of the 78
patients with a cardiac cause of syncope, the diagnosis was
made during the initial evaluation in 36 (46%); in all of
these, the diagnostic test was the standard ECG. Of the 199
patients with a neurally mediated cause of syncope, the
diagnosis was made during the initial evaluation in 51
Table 1. Causes of Syncope (n 5 341)
Cardiac (n 5 78, 23%)
Mechanical or acute ischemia 10 (3%)
Bradyarrhythmic 51 (15%)
Tachyarrhythmic 17 (5%)
Neurally mediated (n 5 199, 58%)
Typical vasovagal 20 (6%)
Situational 25 (7%)
Tilt-induced 94 (27%)
Carotid sinus 47 (14%)
Orthostatic 6 (2%)
Adenosine-sensitive* 7 (2%)
Neurologic or psychiatric (n 5 4, 1%)
Transient ischemic attack 2 (0.5%)
Epilepsy 1 (0.2%)
Hysteria 1 (0.2%)
Unexplained (n 5 60, 18%)
*Adenosine-sensitive syncope was included in the neurally mediated group because it
appears related to a functional mechanism.
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Table 2. Comparison of Clinical Features of Syncope
Variables
Cardiac
(n 5 78)
Neurally Mediated
(n 5 199)
p
Value*
Unexplained
(n 5 60)
Age (yrs) 72 6 13 59 6 21 0.00001 55 6 21
Male gender 49 (62%) 95 (47%) 0.02 38 (63%)†
Suspected or certain heart disease after initial evaluation 74 (95%) 94 (47%) 0.0001 23 (38%)
Cardiovascular drugs 40 (51%) 78 (39%) 18 (30%)
History of syncope
Time (years) between first and last syncopal episode
(median)
1 (0.5–2) 9 (2–20) 0.00001 3 (1–10)†
No. of syncopal episodes (median) 2 (1–3) 3 (2–6) 0.0002 2 (1–5)
History of presyncope 31 (40%) 123 (62%) 28 (46%)
Features of index episode
Predisposing or precipitating factors
Warm place 1 (1%) 14 (7%) 5 (8%)
Crowded place 1 (3%) 19 (10%) 0.02 5 (8%)
Prolonged standing 1 (1%) 17 (9%) 0.03 3 (5%)
Overt tiring 1 (1%) 6 (3%) 4 (7%)
Postprandial period‡ 4 (5%) 32 (16%) 0.02 6 (15%)
Neck turning 1 (1%) 8 (4%) 1 (2%)
Syncope while supine 9 (12%) 5 (3%) 0.002 1 (2%)
Syncope while standing 48 (62%) 119 (60%) 41 (68%)
Syncope while sitting 23 (29%) 63 (32%) 15 (25%)
Supine/upright 4 (5%) 24 (12%) 3 (5%)
Syncope during effort§ 10 (13%) 3 (2%) 0.0001 4 (7%)
Syncope after effort\ 1 (1%) 5 (3%) 1 (2%)
Prodromal symptoms and signs
Absence of prodromes 32 (41%) 65 (33%) 22 (37%)
Duration of prodromes
#10 s 26 (33%) 65 (33%) 22 (28%)
.10 s 17 (22%) 69 (34%) 16 (27%)
Not evaluable 3 (4%) 0 0
Awareness of being about to faint 33 (43%) 83 (42%) 17 (28%)
Blurred vision 26 (33%) 44 (22%) 9 (15%)
Lightheadedness 4 (5%) 19 (10%) 6 (10%)
Diaphoresis 13 (17%) 56 (28%) 0.05 14 (23%)
Palpitations 11 (14%) 22 (11%) 4 (7%)
Nausea 6 (7%) 26 (13%) 6 (10%)
Vomiting 3 (4%) 11 (6%) 0
Abdominal discomfort 1 (1%) 16 (8%) 0.05 3 (5%)
Weakness 13 (17%) 39 (20%) 9 (15%)
Feeling cold 1 (1%) 23 (12%) 0.01 4 (7%)
Feeling warm 8 (10%) 27 (14%) 8 (13%)
Tremors 3 (4%) 10 (5%) 2 (3%)
Yawn 1 (1%) 5 (3%) 0
Pallor¶ 22/40 (55%) 107/133 (80%) 0.002 27/34 (80%)
Red or cyanosis¶ 4/40 (10%) 8/133 (6%) 1/34 (3%)
Syncopal phase
Convulsions¶ 6/40 (15%) 16/133 (12%) 1/34 (3%)
Incontinence 8 (10%) 23 (12%) 3 (5%)
Any injury 28 (36%) 80 (40%) 22 (37%)
Duration of loss of consciousness (s) 33 6 124 30 6 56 19 6 31
Recovery phase
Recovery duration#
#1 min 27 (35%) 51 (26%) 18 (30%)
.1 min, #60 min 39 (50%) 103 (52%) 35 (58%)
.60 min 12 (15%) 42 (21%) 7 (12%)
Not evaluable 0 3 (1.5%) 0
Diaphoresis 13 (17%) 58 (29%) 0.05 14 (23%)
Nausea 4 (5%) 30 (15%) 0.03 4 (7%)
Vomiting 5 (6%) 27 (14%) 5 (8%)
Abdominal discomfort 3 (4%) 10 (5%) 2 (3%)
Weakness 26 (33%) 71 (36%) 21 (35%)
Feeling cold 2 (3%) 31 (16%) 0.003 10 (17%)
Feeling warm 5 (6%) 10 (5%) 4 (7%)
Tremors 2 (3%) 12 (6%) 8 (13%)†
Confusion 21 (27%) 50 (25%) 11 (18%)
*Cardiac versus neurally mediated syncope. †p , 0.05 between unexplained and neurally mediated syncope. ‡Postprandial syncope was defined as a loss of consciousness occurring
during or within 1 h after the meal. §Syncope was defined as effort syncope when the prodromal symptoms began during effort. \Syncope was defined as post-effort syncope when
the symptoms began at just or a few minutes after effort. ¶Evaluated only in the presence of witnesses. The number of witnesses is reported. #The recovery duration was defined
as the time required for resolution of residual symptoms after restoration of consciousness.
Data are reported as the mean value 6 SD, number (%) of patients or median value (range).
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(26%): typical vasovagal or situational syncope in 45 and
orthostatic hypotension in 6.
Comparison of clinical features during syncope. The
clinical features of the patients with cardiac, neurally medi-
ated and unexplained causes of syncope are reported in
Table 2. There were some significant differences between
cardiac and neurally mediated syncope. In contrast, the
clinical features of unexplained syncope were very similar to
those of neurally mediated syncope; indeed, among the
variables examined, only male gender, time between the first
and last syncopal episode and tremors showed significant
differences between the two types of syncope.
We first performed a statistical analysis of the variables
that were not part of the presentation of syncope: age,
gender and the presence of suspected or certain heart disease
after the initial evaluation. On univariate analysis, these
were found to differ. Among these three variables, on
multivariate analysis, the presence of suspected or certain
heart disease was the only independent predictor of a cardiac
cause of syncope (odds ratio 16, 95% confidence interval 5
to 48, p 5 0.00001). Consequently, the patients were
classified into two subgroups: one comprising the 191
patients with heart disease and the other comprising the 146
patients without it. We analyzed the historical variables of
syncope separately in these two subgroups. The results are
reported in Tables 4 and 5. Suspected or certain heart
disease after the initial evaluation was present in 74 (95%) of
78 patients with a final diagnosis of cardiac syncope, but also
in 117 (45%) of 259 of patients who did not have a cardiac
cause of syncope (Fig. 2). In contrast, the absence of
suspected or certain heart disease allowed us to exclude a
cardiac cause of syncope in 142 (97%) of these 146 patients
(Fig. 2).
Patients with suspected or certain heart disease. In the
191 patients with suspected or certain heart disease after the
initial evaluation, the significant univariate predictors of a
cardiac cause of syncope were time between the first and last
syncopal episode #4 years, #2 syncopal episodes, syncope
during effort or in the supine position, blurred vision before
the loss of consciousness and convulsive syncope. On
multivariate analysis, duration of symptoms #4 years, syn-
cope in the supine position and blurred vision remained
independent predictors (Table 4).
Significant univariate predictors of a neurally mediated
cause of syncope were time between the first and last
syncopal episode .4 years, history of presyncope, abdomi-
nal discomfort and pallor before the loss of consciousness
and nausea and diaphoresis during the recovery phase. On
multivariate analysis, duration of symptoms .4 years, his-
tory of presyncope and nausea remained independent pre-
dictors (Table 4).
Patients without suspected or diagnosed heart disease.
In the 146 patients without suspected or diagnosed heart
disease after the initial evaluation, the only significant
univariate predictor of a cardiac cause of syncope was
palpitations before the loss of consciousness. The significant
univariate predictors of a neurally mediated cause of syncope
were $3 syncopal episodes and duration of prodromes
.10 s. On multivariate analysis, duration of prodromes
.10 s remained an independent predictor (Table 5).
Diagnostic value. Sensitivity, specificity and post-test
probability (8) of the significant predictors are reported in
Table 6.
Figure 2. Causes of syncope in patients (pts) with and without suspected or certain heart disease after the initial evaluation.
Table 3. Diagnostic Examinations That Established the Cause
of Syncope (n 5 341)
History/physical examination 46 (14%)
Visit of consultant neurologist or psychiatrist 3 (1%)
Orthostatic blood pressure measurement 6 (2%)
Electrocardiogram 36 (10%)
Echocardiogram 3 (1%)
24-h Holter recording 16 (5%)
Exercise test 2 (0.5%)
Carotid sinus massage 47 (14%)
Tilt test 94 (27%)
Electrophysiologic study 19 (5%)
Pulmonary scintigraphy 2 (0.5%)
Electroencephalogram 1 (0.3%)
ATP test 7 (2%)
Data are presented as the number (%) of patients.
ATP 5 adenosine triphosphate.
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DISCUSSION
Main findings. The presence of suspected or certain heart
disease after the initial evaluation is a strong predictor of a
cardiac cause of syncope, but its specificity is low. In a
minority of patients with suspected or certain heart disease,
there are historical findings predictive of a cardiac cause or
a neurally mediated cause of syncope. The absence of
suspected or diagnosed heart disease allows us to exclude a
cardiac cause of syncope if the patient does not have
palpitations before the loss of consciousness. The clinical
features of unexplained syncope and neurally mediated syncope
are very similar. Our results do not support the usefulness of
the differential diagnosis of some clinical variables commonly
used in clinical practice and previously reported.
Comparison with previous studies. Two previous pro-
spective studies have evaluated the clinical features during
syncope (9,10). Martin et al. (9) obtained the clinical
histories of 170 patients presenting with syncope on arrival
at the emergency room. These authors reported that the
duration of prodromal symptoms was longer for neurally
mediated syncope than for cardiac syncope. We could not
confirm this finding. However, in this study, a presumed
diagnosis was established only at the time of the emergency
room evaluation. Calkins et al. (10) evaluated the clinical
histories in three selected groups of patients with neurally
mediated syncope, syncope due to ventricular tachycardia
and syncope due to AV block. The clinical histories of
patients with syncope due to ventricular tachycardia or AV
block were similar. In contrast, the clinical histories of
patients with neurally mediated syncope differed from those
of patients with cardiac syncope. We confirmed some
features suggestive of neurally mediated syncope, such as
diaphoresis before and after the loss of consciousness and
nausea after the loss of consciousness. Other features sug-
gestive of neurally mediated syncope, such as longer dura-
tion of prodromes, palpitations, nausea and lightheadedness
before syncope and fatigue after the loss of consciousness,
were not confirmed. In the study of Calkins et al. (10),
patients were asked to give a description of their two most
recent syncopal episodes. For this reason, the prevalence of
symptoms was very likely overestimated, and the description
could not be precise, as the time between two syncopal
episodes is often long. Moreover, it is not clear how the
duration of prodromes was evaluated. It must also be
considered that the results will be different according to
whether a study is carried out in a selected group of patients
or in an unselected group (consecutive patients).
Results of the present study. On the basis of specific
diagnostic criteria, the cause of syncope was established in
281 patients (82%) and remained unexplained in 60 (18%);
the prevalence in the latter group was lower than that
reported in five previous studies performed in the 1980s
Table 4. Predictors of the Cause of Syncope in Patients With Suspected or Certain Heart Disease After the Initial Evaluation
(n 5 191)
Univariate Analysis Multivariate Analysis
OR 95% CI p Value OR 95% CI p Value
Predictors of cardiac syncope
Time between first and last syncopal episode #4 years 14 4–51 0.0004 55 6–471 0.0002
Convulsions 10.2 1.2–88 0.03
During supine position 7.9 1.6–38 0.01 69 4–1,087 0.002
During effort 3.1 1–9.7 0.05
Blurred vision (prodrome) 2.5 1.2–5 0.01 4.7 1.3–17 0.01
#2 syncopal episodes 2.3 1.2–4.2 0.01
Predictors of neurally mediated syncope
Abdominal discomfort (prodrome) 8.9 1–74 0.04
Time between first and last syncopal episode .4 years 7.7 3–18 0.000001 9.2 4–25 0.000001
Nausea (recovery) 2.9 1–8 0.05 6 1–35 0.05
Diaphoresis (recovery) 2.3 1–5 0.02
Pallor 2 1–4 0.05
History of presyncope 2 1–4 0.02 2.7 1.1–7 0.02
CI 5 confidence interval; OR 5 odds ratio.
Table 5. Predictors of the Cause of Syncope in Patients Without Suspected or Diagnosed Heart Disease After the Initial Evaluation
(n 5 146)
Univariate Analysis Multivariate Analysis
OR 95% CI p Value OR 95% CI p Value
Predictors of cardiac syncope
Palpitations 21 2–214 0.01
Predictors of neurally mediated syncope
Duration of prodromes .10 s 3.7 1.2–11 0.02 3.5 1.1–11 0.03
$3 syncopal episodes 2.8 1.3–6 0.006
CI 5 confidence interval; OR 5 odds ratio.
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(mean 34%) (9,11–14), probably because of a more extensive
utilization of carotid sinus massage, tilt testing and electro-
physiology.
The clinical features of unexplained syncope and neurally
mediated syncope were very similar (Table 2). This suggests
that unexplained syncope is, at least in the vast majority of
patients, a neurally mediated syncope that is difficult to
diagnose with currently utilized tools.
The absence of prodromal symptoms was similar between
cardiac and neurally mediated syncope (41% and 33%,
respectively); therefore, this factor is not useful for diagnos-
ing the cause of syncope. The duration of the loss of
consciousness and the duration of the recovery phase were
also similar between these two types of syncope.
Symptoms and signs, such as nausea, vomiting before the
loss of consciousness, pallor, weakness, lightheadedness and
yawning, which have been used up to now in clinical
practice and considered very suggestive of neurally mediated
syncope, even in the absence of a clinical investigation, show
a similar prevalence in cardiac and neurally mediated syn-
cope (Table 2) and, therefore, are not indicative of the type
of syncope. These results suggest that activation of the
autonomic system occur in all types of syncope. In addition,
the prevalence of incontinence and injury was similar in all
types of syncope.
Study limitations. In syncope, there is no diagnostic “gold”
standard against which other diagnostic tests may be mea-
sured; therefore, no set of criteria and no algorithm for
diagnosing syncope may be considered ideal. The diagnostic
criteria we employed in the present study are those most
commonly used; they were also officially accepted by the
Italian Cardiological Association (1,2).
The prevalence of neurologic or psychiatric loss of con-
sciousness was low (1%). It is possible that this result does
not express the true prevalence of this type of loss of
consciousness, because it is presumable that patients with
seizure disorders or with loss of consciousness associated
with focal neurologic symptoms went directly, or through
the emergency room, to the neurology department. A
similar low prevalence was reported in previous studies
(9,12,15,16). The prevalence of typical vasovagal syncope
may also be underestimated, as a population study showed
that only 23% of patients with this type of syncope are
referred to the hospital (17). For these reasons, the results of
the present study seem to reflect the distribution of patients
who are referred to the syncope unit, rather than the distribu-
tion of patients with syncope in the general population.
Abnormal neural reflexes have been shown to play an
important role in the genesis of syncope in patients with
sinus node dysfunction or with paroxysmal supraventricular
tachyarrhythmias (18–21). Therefore, the diagnosis of ar-
rhythmic syncope may constitute a simplification.
Clinical implications. In clinical practice, patients with
syncope undergo several examinations, very often with
negative results. The results of the present study suggest a
practical strategy for evaluation of patients with syncope.
We have demonstrated that the presence of suspected or
certain heart disease after the initial evaluation is a predictor
Table 6. Sensitivity, Specificity and Post-Test Probability of the Variables Predictive of Cardiac and Neurally Mediated Causes of
Syncope in Patients With and Without Suspected or Certain Heart Disease After the Initial Evaluation
Patients With Suspected or Certain Heart Disease
Sensitivity Specificity
Post-Test
Probability
Predictors of cardiac syncope
Time between first and last syncopal episode #4 years 98% 41% 50%
Convulsions 16% 99% 90%
During supine position 12% 98% 79%
During effort 14% 96% 68%
Blurred vision (prodrome) 35% 85% 59%
#2 syncopal episodes 66% 48% 44%
Predictors of neurally mediated syncope
Abdominal discomfort (prodrome) 8% 99% 88%
Time between first and last syncopal episode .4 years 40% 87% 74%
Pallor (prodrome) 72% 43% 55%
Nausea (recovery) 14% 96% 77%
Diaphoresis (recovery) 30% 84% 64%
History of presyncope 56% 60% 57%
Patients Without Suspected or Certain Heart Disease
Sensitivity Specificity
Post-Test
Probability
Predictors of cardiac syncope
Palpitations 75% 87% 14%
Predictors of neurally mediated syncope
Duration of prodromes .10 s 39% 70% 76%
$3 syncopal episodes 68% 51% 77%
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of a cardiac cause of syncope, as already reported by Martin
et al. (22), although its specificity is low.
Thus, the presence or absence of heart disease should be
investigated first. In the presence of heart disease, some
variables (e.g., blurred vision, syncope occurring in the
supine position or during effort or convulsive syncope)
suggest a cardiac cause of syncope, with a high specificity.
The presence of these variables increases the pre-test prob-
ability of a cardiac cause of syncope. For example, in a
patient with suspected or certain heart disease, the diagnosis
of a cardiac cause of syncope is increased from a pre-test
probability of 39% (Fig. 2) to a post-test probability of 79%
when syncope occurs in the supine position (Table 6).
Therefore, these patients should probably be admitted to
the hospital, and cardiac examinations should be given
priority. In contrast, a long duration (.4 years) of symp-
toms and syncope preceded by abdominal discomfort or
followed by nausea and diaphoresis suggest a neurally
mediated cause of syncope, with a high specificity and an
increased post-test probability. In these cases, autonomic
tests should be given priority, and, if they are positive, a
neurally mediated mechanism is likely, and the diagnostic
work-up should be stopped. However, it must be empha-
sized that the sensitivity of the most specific predictors is
quite low (Table 6), and, therefore, they can be useful only
in a minority of patients.
When heart disease is absent, a cardiac cause is unlikely,
unless palpitations precede syncope. In the latter case, the
possibility that a tachyarrhythmia is the cause of syncope
should be evaluated. In the other cases, autonomic tests
should be performed to evaluate the possible neurally
mediated nature of syncope. Patients usually do not need to
be admitted to the hospital, given the benign outcome of
this type of syncope.
The results of the present study can optimize the work-up
of syncope, avoiding useless tests and reducing the high
diagnostic costs in patients with syncope (23).
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